📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia. (2018)

First Author: Marshall LE
Attributed to:  Development and testing of novel recombinant pnemococcal glyconjugate vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1155/2018/8087916

PubMed Identifier: 30622981

Publication URI: http://europepmc.org/abstract/MED/30622981

Type: Journal Article/Review

Volume: 2018

Parent Publication: Journal of immunology research

ISSN: 2314-7156